Literature DB >> 19558278

Achieving hemostasis in the surgical field.

Bradley A Boucher1, Oren Traub.   

Abstract

Hemostatic mechanisms are an integral part of the human physiology. Traditionally divided into intrinsic and extrinsic arms, the coagulation cascade converges, through the interactions of many different factors, at a common element-thrombin. As a consequence, a number of different agents have been developed to supplement this common, critical step to aid surgical hemostasis. Intraoperative interventions most commonly include sutures and heat-generating cautery devices; however, these methods are sometimes insufficient or inappropriate for a specific procedure or anatomic location, leading to the development of other adjunctive therapies, including topical hemostats. Topical hemostatic agents generally act as active, passive, and combinations therapies, depending on their individual composition and mode of action. We provide a brief review of the normal coagulation cascade, including critical points, followed by a discussion of surgical strategies and adjuctive therapies used to achieve surgical hemostasis and concluding with a discussion of topical thrombins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558278     DOI: 10.1592/phco.29.pt2.2S

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery.

Authors:  Robert Öllinger; Andre L Mihaljevic; Christoph Schuhmacher; Hüseyin Bektas; Florian Vondran; Moritz Kleine; Mauricio Sainz-Barriga; Sascha Weiss; Phillip Knebel; Johann Pratschke; Roberto I Troisi
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

2.  Evolution of hemostatic agents in surgical practice.

Authors:  Chandru P Sundaram; Alison C Keenan
Journal:  Indian J Urol       Date:  2010-07

3.  A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding.

Authors:  Mitra Corral; Nicole Ferko; Andrew Hogan; Sarah S Hollmann; Gaurav Gangoli; Nadine Jamous; Jonathan Batiller; Richard Kocharian
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-21

4.  Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations.

Authors:  Nicholas C Dang; Abbas Ardehali; Brian A Bruckner; Patrick E Parrino; Daniel L Gillen; Rachel W Hoffman; Russell Spotnitz; Stephanie Cavoores; Ian J Shorn; Roberto J Manson; William D Spotnitz
Journal:  J Card Surg       Date:  2019-11-25       Impact factor: 1.620

5.  ISO 10993 biological evaluation of novel hemostatic powder - 4SEAL®.

Authors:  Lukasz Szymanski; Kamila Golaszewska; Anna Wiatrowska; Monika Dropik; Pawel Szymanski; Bartosz Gromadka; Patrycja Krakowiak; Justyna Wierzchowska; Damian Matak
Journal:  Biomater Res       Date:  2022-04-05

6.  Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.

Authors:  Kevin M Lewis; Holly D Atlee; Angela J Mannone; Joseph Dwyer; Lawrence Lin; Andreas Goppelt; Heinz Redl
Journal:  J Invest Surg       Date:  2013-03-20       Impact factor: 2.533

7.  Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database.

Authors:  Mitra Corral; Nicole Ferko; Sarah Hollmann; Michael S Broder; Eunice Chang
Journal:  Clinicoecon Outcomes Res       Date:  2015-07-22

8.  A nanostructured synthetic collagen mimic for hemostasis.

Authors:  Vivek A Kumar; Nichole L Taylor; Abhishek A Jalan; Lyahn K Hwang; Benjamin K Wang; Jeffery D Hartgerink
Journal:  Biomacromolecules       Date:  2014-04-02       Impact factor: 6.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.